Pim-2 expression was found to be higher in the ABC-DLBCL subtype than the GC subtype; whereby Pim inhibition with ETP-39010 or Pim2 knock-down decreased BAD (Bcl2 associated antagonist of cell death), AKT, and 4E-BP1. Here, PIM1 is linked to diffuse large B-cell lymphoma.